Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama
Fatal opioid overdoses remain the leading cause of accidental deaths in the United States, which have contributed to implementation of standing order laws that allow pharmacists to dispense naloxone to patients. Although pharmacy distribution of naloxone is a promising approach to increase access to...
Gespeichert in:
Veröffentlicht in: | The International journal of drug policy 2019-12, Vol.74, p.229-235 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 235 |
---|---|
container_issue | |
container_start_page | 229 |
container_title | The International journal of drug policy |
container_volume | 74 |
creator | Sisson, Michelle L. McMahan, Kristina B. Chichester, Keith R. Galbraith, James W. Cropsey, Karen L. |
description | Fatal opioid overdoses remain the leading cause of accidental deaths in the United States, which have contributed to implementation of standing order laws that allow pharmacists to dispense naloxone to patients. Although pharmacy distribution of naloxone is a promising approach to increase access to this intervention, understanding barriers preventing greater uptake of this service is needed.
Data for the current study were collected via telephone survey assessing the availability of various formulations of naloxone at chain and independent pharmacies in rural and urban areas in Birmingham, Alabama (N = 222). Pharmacists’ attitudes toward naloxone and potential barriers of pharmacy naloxone distribution were also assessed. One-way analysis of variance (ANOVA) and logistic regression analyses were utilized to examine differences in stocking of naloxone in chain and independent pharmacies and to determine predictors of the number of kits dispensed by pharmacies.
Independent pharmacies were less likely to have naloxone in stock, especially those in rural areas. Furthermore, rural pharmacies required more time to obtain all four formulations of naloxone, and offered less extensive training on naloxone use. Pharmacists endorsing the belief that naloxone allows avoidance of emergent treatment in an overdose situation was associated with fewer dispensed kits by the pharmacies. Over 80% of pharmacists endorsed at least one negative belief about naloxone (e.g., allowing riskier opioid use). Pharmacists noted cost to patients and the pharmacy as contributing to not dispensing more naloxone kits.
The current study demonstrates the lower availability of naloxone stocked at pharmacies in independent versus chain pharmacies, particularly in rural communities. This study also highlights several barriers preventing greater naloxone dispensing including pharmacists’ attitudes and costs of naloxone. The potential benefit of standing order laws is not being fully actualized due to the structural and attitudinal barriers identified in this study. Strategies to increase naloxone access through pharmacy dispensing are discussed. |
doi_str_mv | 10.1016/j.drugpo.2019.09.021 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2313359180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0955395919302646</els_id><sourcerecordid>2334202727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-4400df9bf0ce10efa0a6792022df153d05a006ca50dc063f062a35b4eb48779f3</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7rj6DUQCXrz0WOl0uicehGHxHyx40XOoTqp3M3QnbdK9uJ_BL21mZvXgQSioQ_3qPXiPsZcCtgJE-_awdWm9meO2BqG3UKYWj9hG7DpZNZ3aPWYb0EpVUit9wZ7lfACARjTiKbuQotU70aoN-7VfFr-sjjLH4DjeoR-x96Nf7t_xPbdxmjH5HAOPAw84xp8xEHc-zxSyDzccbYo5c3uLPpwkfHBUjo7CwudbTBNaX9TLNa0JxxOzph4LnQhPh32xxAmfsycDjplePOxL9v3jh29Xn6vrr5--XO2vKys1LFXTALhB9wNYEkADAradrqGu3SCUdKAQoLWowFlo5QBtjVL1DfXNruv0IC_Zm7PunOKPlfJiJp8tjSMGims2tRRSKi12UNDX_6CHuKaSw5GSTTHt6q5QzZk6ZZFoMHPyE6Z7I8AcyzIHcy7LHMsyUKYW5e3Vg_jaT-T-Pv1ppwDvzwCVNO48JZNLlsGS84nsYlz0_3f4DVWDqOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2334202727</pqid></control><display><type>article</type><title>Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>PAIS Index</source><source>Elsevier ScienceDirect Journals</source><creator>Sisson, Michelle L. ; McMahan, Kristina B. ; Chichester, Keith R. ; Galbraith, James W. ; Cropsey, Karen L.</creator><creatorcontrib>Sisson, Michelle L. ; McMahan, Kristina B. ; Chichester, Keith R. ; Galbraith, James W. ; Cropsey, Karen L.</creatorcontrib><description>Fatal opioid overdoses remain the leading cause of accidental deaths in the United States, which have contributed to implementation of standing order laws that allow pharmacists to dispense naloxone to patients. Although pharmacy distribution of naloxone is a promising approach to increase access to this intervention, understanding barriers preventing greater uptake of this service is needed.
Data for the current study were collected via telephone survey assessing the availability of various formulations of naloxone at chain and independent pharmacies in rural and urban areas in Birmingham, Alabama (N = 222). Pharmacists’ attitudes toward naloxone and potential barriers of pharmacy naloxone distribution were also assessed. One-way analysis of variance (ANOVA) and logistic regression analyses were utilized to examine differences in stocking of naloxone in chain and independent pharmacies and to determine predictors of the number of kits dispensed by pharmacies.
Independent pharmacies were less likely to have naloxone in stock, especially those in rural areas. Furthermore, rural pharmacies required more time to obtain all four formulations of naloxone, and offered less extensive training on naloxone use. Pharmacists endorsing the belief that naloxone allows avoidance of emergent treatment in an overdose situation was associated with fewer dispensed kits by the pharmacies. Over 80% of pharmacists endorsed at least one negative belief about naloxone (e.g., allowing riskier opioid use). Pharmacists noted cost to patients and the pharmacy as contributing to not dispensing more naloxone kits.
The current study demonstrates the lower availability of naloxone stocked at pharmacies in independent versus chain pharmacies, particularly in rural communities. This study also highlights several barriers preventing greater naloxone dispensing including pharmacists’ attitudes and costs of naloxone. The potential benefit of standing order laws is not being fully actualized due to the structural and attitudinal barriers identified in this study. Strategies to increase naloxone access through pharmacy dispensing are discussed.</description><identifier>ISSN: 0955-3959</identifier><identifier>EISSN: 1873-4758</identifier><identifier>DOI: 10.1016/j.drugpo.2019.09.021</identifier><identifier>PMID: 31698165</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Access ; Attitudes ; Availability ; Barriers ; Drug policy ; Independent drug stores ; Intervention ; Naloxone ; Narcotics ; Opioids ; Overdoses ; Patients ; Pharmacies ; Pharmacists ; Pharmacy ; Rural areas ; Rural communities ; Rural urban differences ; Telephone surveys ; Uptake ; Urban areas ; Variance analysis</subject><ispartof>The International journal of drug policy, 2019-12, Vol.74, p.229-235</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Dec 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-4400df9bf0ce10efa0a6792022df153d05a006ca50dc063f062a35b4eb48779f3</citedby><cites>FETCH-LOGICAL-c390t-4400df9bf0ce10efa0a6792022df153d05a006ca50dc063f062a35b4eb48779f3</cites><orcidid>0000-0001-6921-3440</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0955395919302646$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27843,27901,27902,30976,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31698165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sisson, Michelle L.</creatorcontrib><creatorcontrib>McMahan, Kristina B.</creatorcontrib><creatorcontrib>Chichester, Keith R.</creatorcontrib><creatorcontrib>Galbraith, James W.</creatorcontrib><creatorcontrib>Cropsey, Karen L.</creatorcontrib><title>Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama</title><title>The International journal of drug policy</title><addtitle>Int J Drug Policy</addtitle><description>Fatal opioid overdoses remain the leading cause of accidental deaths in the United States, which have contributed to implementation of standing order laws that allow pharmacists to dispense naloxone to patients. Although pharmacy distribution of naloxone is a promising approach to increase access to this intervention, understanding barriers preventing greater uptake of this service is needed.
Data for the current study were collected via telephone survey assessing the availability of various formulations of naloxone at chain and independent pharmacies in rural and urban areas in Birmingham, Alabama (N = 222). Pharmacists’ attitudes toward naloxone and potential barriers of pharmacy naloxone distribution were also assessed. One-way analysis of variance (ANOVA) and logistic regression analyses were utilized to examine differences in stocking of naloxone in chain and independent pharmacies and to determine predictors of the number of kits dispensed by pharmacies.
Independent pharmacies were less likely to have naloxone in stock, especially those in rural areas. Furthermore, rural pharmacies required more time to obtain all four formulations of naloxone, and offered less extensive training on naloxone use. Pharmacists endorsing the belief that naloxone allows avoidance of emergent treatment in an overdose situation was associated with fewer dispensed kits by the pharmacies. Over 80% of pharmacists endorsed at least one negative belief about naloxone (e.g., allowing riskier opioid use). Pharmacists noted cost to patients and the pharmacy as contributing to not dispensing more naloxone kits.
The current study demonstrates the lower availability of naloxone stocked at pharmacies in independent versus chain pharmacies, particularly in rural communities. This study also highlights several barriers preventing greater naloxone dispensing including pharmacists’ attitudes and costs of naloxone. The potential benefit of standing order laws is not being fully actualized due to the structural and attitudinal barriers identified in this study. Strategies to increase naloxone access through pharmacy dispensing are discussed.</description><subject>Access</subject><subject>Attitudes</subject><subject>Availability</subject><subject>Barriers</subject><subject>Drug policy</subject><subject>Independent drug stores</subject><subject>Intervention</subject><subject>Naloxone</subject><subject>Narcotics</subject><subject>Opioids</subject><subject>Overdoses</subject><subject>Patients</subject><subject>Pharmacies</subject><subject>Pharmacists</subject><subject>Pharmacy</subject><subject>Rural areas</subject><subject>Rural communities</subject><subject>Rural urban differences</subject><subject>Telephone surveys</subject><subject>Uptake</subject><subject>Urban areas</subject><subject>Variance analysis</subject><issn>0955-3959</issn><issn>1873-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>7TQ</sourceid><recordid>eNp9kU-LFDEQxYMo7rj6DUQCXrz0WOl0uicehGHxHyx40XOoTqp3M3QnbdK9uJ_BL21mZvXgQSioQ_3qPXiPsZcCtgJE-_awdWm9meO2BqG3UKYWj9hG7DpZNZ3aPWYb0EpVUit9wZ7lfACARjTiKbuQotU70aoN-7VfFr-sjjLH4DjeoR-x96Nf7t_xPbdxmjH5HAOPAw84xp8xEHc-zxSyDzccbYo5c3uLPpwkfHBUjo7CwudbTBNaX9TLNa0JxxOzph4LnQhPh32xxAmfsycDjplePOxL9v3jh29Xn6vrr5--XO2vKys1LFXTALhB9wNYEkADAradrqGu3SCUdKAQoLWowFlo5QBtjVL1DfXNruv0IC_Zm7PunOKPlfJiJp8tjSMGims2tRRSKi12UNDX_6CHuKaSw5GSTTHt6q5QzZk6ZZFoMHPyE6Z7I8AcyzIHcy7LHMsyUKYW5e3Vg_jaT-T-Pv1ppwDvzwCVNO48JZNLlsGS84nsYlz0_3f4DVWDqOg</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Sisson, Michelle L.</creator><creator>McMahan, Kristina B.</creator><creator>Chichester, Keith R.</creator><creator>Galbraith, James W.</creator><creator>Cropsey, Karen L.</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TQ</scope><scope>8BJ</scope><scope>DHY</scope><scope>DON</scope><scope>FQK</scope><scope>JBE</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6921-3440</orcidid></search><sort><creationdate>201912</creationdate><title>Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama</title><author>Sisson, Michelle L. ; McMahan, Kristina B. ; Chichester, Keith R. ; Galbraith, James W. ; Cropsey, Karen L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-4400df9bf0ce10efa0a6792022df153d05a006ca50dc063f062a35b4eb48779f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Access</topic><topic>Attitudes</topic><topic>Availability</topic><topic>Barriers</topic><topic>Drug policy</topic><topic>Independent drug stores</topic><topic>Intervention</topic><topic>Naloxone</topic><topic>Narcotics</topic><topic>Opioids</topic><topic>Overdoses</topic><topic>Patients</topic><topic>Pharmacies</topic><topic>Pharmacists</topic><topic>Pharmacy</topic><topic>Rural areas</topic><topic>Rural communities</topic><topic>Rural urban differences</topic><topic>Telephone surveys</topic><topic>Uptake</topic><topic>Urban areas</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sisson, Michelle L.</creatorcontrib><creatorcontrib>McMahan, Kristina B.</creatorcontrib><creatorcontrib>Chichester, Keith R.</creatorcontrib><creatorcontrib>Galbraith, James W.</creatorcontrib><creatorcontrib>Cropsey, Karen L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PAIS Index</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of drug policy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sisson, Michelle L.</au><au>McMahan, Kristina B.</au><au>Chichester, Keith R.</au><au>Galbraith, James W.</au><au>Cropsey, Karen L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama</atitle><jtitle>The International journal of drug policy</jtitle><addtitle>Int J Drug Policy</addtitle><date>2019-12</date><risdate>2019</risdate><volume>74</volume><spage>229</spage><epage>235</epage><pages>229-235</pages><issn>0955-3959</issn><eissn>1873-4758</eissn><abstract>Fatal opioid overdoses remain the leading cause of accidental deaths in the United States, which have contributed to implementation of standing order laws that allow pharmacists to dispense naloxone to patients. Although pharmacy distribution of naloxone is a promising approach to increase access to this intervention, understanding barriers preventing greater uptake of this service is needed.
Data for the current study were collected via telephone survey assessing the availability of various formulations of naloxone at chain and independent pharmacies in rural and urban areas in Birmingham, Alabama (N = 222). Pharmacists’ attitudes toward naloxone and potential barriers of pharmacy naloxone distribution were also assessed. One-way analysis of variance (ANOVA) and logistic regression analyses were utilized to examine differences in stocking of naloxone in chain and independent pharmacies and to determine predictors of the number of kits dispensed by pharmacies.
Independent pharmacies were less likely to have naloxone in stock, especially those in rural areas. Furthermore, rural pharmacies required more time to obtain all four formulations of naloxone, and offered less extensive training on naloxone use. Pharmacists endorsing the belief that naloxone allows avoidance of emergent treatment in an overdose situation was associated with fewer dispensed kits by the pharmacies. Over 80% of pharmacists endorsed at least one negative belief about naloxone (e.g., allowing riskier opioid use). Pharmacists noted cost to patients and the pharmacy as contributing to not dispensing more naloxone kits.
The current study demonstrates the lower availability of naloxone stocked at pharmacies in independent versus chain pharmacies, particularly in rural communities. This study also highlights several barriers preventing greater naloxone dispensing including pharmacists’ attitudes and costs of naloxone. The potential benefit of standing order laws is not being fully actualized due to the structural and attitudinal barriers identified in this study. Strategies to increase naloxone access through pharmacy dispensing are discussed.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31698165</pmid><doi>10.1016/j.drugpo.2019.09.021</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6921-3440</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0955-3959 |
ispartof | The International journal of drug policy, 2019-12, Vol.74, p.229-235 |
issn | 0955-3959 1873-4758 |
language | eng |
recordid | cdi_proquest_miscellaneous_2313359180 |
source | Applied Social Sciences Index & Abstracts (ASSIA); PAIS Index; Elsevier ScienceDirect Journals |
subjects | Access Attitudes Availability Barriers Drug policy Independent drug stores Intervention Naloxone Narcotics Opioids Overdoses Patients Pharmacies Pharmacists Pharmacy Rural areas Rural communities Rural urban differences Telephone surveys Uptake Urban areas Variance analysis |
title | Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A49%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attitudes%20and%20availability:%20A%20comparison%20of%20naloxone%20dispensing%20across%20chain%20and%20independent%20pharmacies%20in%20rural%20and%20urban%20areas%20in%20Alabama&rft.jtitle=The%20International%20journal%20of%20drug%20policy&rft.au=Sisson,%20Michelle%20L.&rft.date=2019-12&rft.volume=74&rft.spage=229&rft.epage=235&rft.pages=229-235&rft.issn=0955-3959&rft.eissn=1873-4758&rft_id=info:doi/10.1016/j.drugpo.2019.09.021&rft_dat=%3Cproquest_cross%3E2334202727%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2334202727&rft_id=info:pmid/31698165&rft_els_id=S0955395919302646&rfr_iscdi=true |